Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-9172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study ; volume:12 ; number:11 ; day:28 ; month:9 ; year:2022 ; pages:2613-2626 ; date:11.2022
Dermatology and therapy ; 12, Heft 11 (28.9.2022), 2613-2626, 11.2022
- Creator
-
Pellegrini, Cristina
Esposito, Maria
Rossi, Ernesto
Gisondi, Paolo
Piaserico, Stefano
Dapavo, Paolo
Conti, Andrea
Gambardella, Alessio
Burlando, Martina
Narcisi, Alessandra
Offidani, Annamaria
Balestri, Riccardo
Bardazzi, Federico
Prignano, Francesca
Mugheddu, Cristina
Romanelli, Marco
Malara, Giovanna
Schinzari, Giovanni
Fargnoli, Maria Concetta
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-022-00797-9
- URN
-
urn:nbn:de:101:1-2023010621103217634675
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pellegrini, Cristina
- Esposito, Maria
- Rossi, Ernesto
- Gisondi, Paolo
- Piaserico, Stefano
- Dapavo, Paolo
- Conti, Andrea
- Gambardella, Alessio
- Burlando, Martina
- Narcisi, Alessandra
- Offidani, Annamaria
- Balestri, Riccardo
- Bardazzi, Federico
- Prignano, Francesca
- Mugheddu, Cristina
- Romanelli, Marco
- Malara, Giovanna
- Schinzari, Giovanni
- Fargnoli, Maria Concetta
- SpringerLink (Online service)
Other Objects (12)
Secukinumab (Cosentyx®) flexibel dosieren bei Plaque-Psoriasis
Behandlung der Psoriasis mit Secukinumab : Praxisrelevante Hinweise
Secukinumab (Plaque-Psoriasis) : Addendum zum Auftrag A17-08
Secukinumab (Psoriasis-Arthritis) : Addendum zum Auftrag A20-80
Secukinumab wirksam bei axialen Manifestationen der Psoriasis-Arthritis
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort
Identification immune response genes in psoriasis after treatment with secukinumab
Secukinumab und Ixekizumab bei Psoriasis: Beträchtlicher Zusatznutzen für bestimmte Patienten
Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis
Secukinumab (Cosentyx) : frühe und effektive Behandlung mittelschwerer bis schwerer Plaque-Psoriasis
Efficacy of Secukinumab for Plaque Psoriasis in a Patient on Hemodialysis
Prurigo Nodularis onset during secukinumab treatment of psoriasis: a case report
Secukinumab (Cosentyx®) flexibel dosieren bei Plaque-Psoriasis
Behandlung der Psoriasis mit Secukinumab : Praxisrelevante Hinweise
Secukinumab (Plaque-Psoriasis) : Addendum zum Auftrag A17-08
Secukinumab (Psoriasis-Arthritis) : Addendum zum Auftrag A20-80
Secukinumab wirksam bei axialen Manifestationen der Psoriasis-Arthritis
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort
Identification immune response genes in psoriasis after treatment with secukinumab
Secukinumab und Ixekizumab bei Psoriasis: Beträchtlicher Zusatznutzen für bestimmte Patienten
Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis
Secukinumab (Cosentyx) : frühe und effektive Behandlung mittelschwerer bis schwerer Plaque-Psoriasis
Efficacy of Secukinumab for Plaque Psoriasis in a Patient on Hemodialysis
Prurigo Nodularis onset during secukinumab treatment of psoriasis: a case report
Secukinumab (Cosentyx®) flexibel dosieren bei Plaque-Psoriasis
Behandlung der Psoriasis mit Secukinumab : Praxisrelevante Hinweise
Secukinumab (Plaque-Psoriasis) : Addendum zum Auftrag A17-08
Secukinumab (Psoriasis-Arthritis) : Addendum zum Auftrag A20-80
Secukinumab wirksam bei axialen Manifestationen der Psoriasis-Arthritis
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort
Identification immune response genes in psoriasis after treatment with secukinumab
Secukinumab und Ixekizumab bei Psoriasis: Beträchtlicher Zusatznutzen für bestimmte Patienten
Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis
Secukinumab (Cosentyx) : frühe und effektive Behandlung mittelschwerer bis schwerer Plaque-Psoriasis
Efficacy of Secukinumab for Plaque Psoriasis in a Patient on Hemodialysis